The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function

NCT02473809 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Complications
Osteoporosis

Interventions

DRUG: Liraglutide
DRUG: Placebo

Sponsor

University of Aarhus

Collaborators

[object Object]
[object Object]